| The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ... Leukemia 36 (7), 1720-1748, 2022 | 1530 | 2022 |
| COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 619 | 2020 |
| Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993 HM Lazarus, SM Richards, R Chopra, MR Litzow, AK Burnett, PH Wiernik, ... Blood 108 (2), 465-472, 2006 | 254 | 2006 |
| Revised adult T-cell leukemia-lymphoma international consensus meeting report LB Cook, S Fuji, O Hermine, A Bazarbachi, JC Ramos, L Ratner, ... Journal of Clinical Oncology 37 (8), 677, 2019 | 208 | 2019 |
| The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma LB Cook, A Melamed, H Niederer, M Valganon, D Laydon, L Foroni, ... Blood, The Journal of the American Society of Hematology 123 (25), 3925-3931, 2014 | 134 | 2014 |
| HTLV-1: persistence and pathogenesis LB Cook, M Elemans, AG Rowan, B Asquith Virology 435 (1), 131-140, 2013 | 127 | 2013 |
| HTLV-1–infected T cells contain a single integrated provirus in natural infection LB Cook, AG Rowan, A Melamed, GP Taylor, CRM Bangham Blood, The Journal of the American Society of Hematology 120 (17), 3488-3490, 2012 | 108 | 2012 |
| HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection CRM Bangham, LB Cook, A Melamed Seminars in cancer biology 26, 89-98, 2014 | 102 | 2014 |
| Genomic profiling for clinical decision making in lymphoid neoplasms L De Leval, AA Alizadeh, PL Bergsagel, E Campo, A Davies, A Dogan, ... Blood, The Journal of the American Society of Hematology 140 (21), 2193-2227, 2022 | 79 | 2022 |
| Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients LBM Cook, A Melamed, MA Demontis, DJ Laydon, JM Fox, JHC Tosswill, ... Retrovirology 13, 1-9, 2016 | 76 | 2016 |
| Management of paraproteinaemia L Cook, DHC Macdonald Postgraduate medical journal 83 (978), 217-223, 2007 | 69 | 2007 |
| Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma AA Phillips, PA Fields, O Hermine, JC Ramos, BE Beltran, J Pereira, ... haematologica 104 (5), 993, 2019 | 66 | 2019 |
| Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo NA Gillet, L Cook, DJ Laydon, C Hlela, K Verdonck, C Alvarez, E Gotuzzo, ... PLoS pathogens 9 (4), e1003263, 2013 | 65 | 2013 |
| How I treat adult T-cell leukemia/lymphoma LB Cook, AA Phillips Blood, The Journal of the American Society of Hematology 137 (4), 459-470, 2021 | 53 | 2021 |
| Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19 C Várnai, C Palles, R Arnold, HM Curley, K Purshouse, VWT Cheng, ... JAMA network open 5 (2), e220130-e220130, 2022 | 49 | 2022 |
| Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia/lymphoma diagnosis AG Rowan, R Dillon, A Witkover, A Melamed, MA Demontis, NA Gillet, ... Blood, The Journal of the American Society of Hematology 135 (23), 2023-2032, 2020 | 49 | 2020 |
| Medical Research Council (MRC)/National Cancer Research Institute (NCRI) Adult Leukaemia Working Party of the United Kingdom and the Eastern Cooperative Oncology Group. Central … HM Lazarus, SM Richards, R Chopra, MR Litzow, AK Burnett, PH Wiernik, ... Blood 108 (2), 465-472, 2006 | 45 | 2006 |
| Ruxolitinib for tocilizumab‐refractory severe COVID‐19 infection AJ Innes, LB Cook, S Marks, E Bataillard, C Crossette‐Thambiah, ... British Journal of Haematology 190 (4), e198, 2020 | 41 | 2020 |
| The impact of HTLV-1 on the cellular genome L Cook, A Melamed, H Yaguchi, CRM Bangham Current opinion in virology 26, 125-131, 2017 | 33 | 2017 |
| Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti … S Booth, HM Curley, C Varnai, R Arnold, LYW Lee, NA Campton, G Cook, ... British Journal of Haematology 196 (4), 892-901, 2022 | 31 | 2022 |
